{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:11:38Z","timestamp":1789567898445,"version":"build-2803163510"},"reference-count":62,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2026-0158_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study investigated the effects of ART on the cardiometabolic health of HIV-infected women during late pregnancy and its relationship with adverse outcomes in exposed newborns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2026-0158_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional study conducted among pregnant women living with HIV (pWLWH) on ART and HIV-uninfected pregnant women (controls) in their third trimester. Data on maternal gynaeco-obstetric history and cardiovascular health were collected. At birth, anthropometric measures and placental cord blood samples from newborns were collected to assess lipidaemia, glycaemia, oxidative stress, endothelial function, and inflammatory markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2026-0158_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>More pWLWH had previously had hypertension compared (p&gt;0.05) to HIV-uninfected pregnant women (HUPW). Blood creatinine and 8-hydroxydeoxyguanosine were higher, while tumour necrosis factor-alpha and vascular endothelial growth factor receptor were lower in newborns of HIV-infected mothers on ART (HIMA) compared to newborns of HIV-uninfected mothers (HUM) (p&lt;0.05). Similarly, the APGAR scores after 1 and 5\u202fmin were lower in newborns of HIMA compared to newborns of HUM (p&lt;0.05). The prevalence of low birth weight (LBW) was higher (p&lt;0.05) in newborns of HIMA (13.2\u202f%) compared to newborns of HUM (8.2\u202f%). Newborns of HIMA were 3.3\u00a0times (OR: 3.302; p&lt;0.01) more likely to present LBW compared to newborns of\u00a0HUM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2026-0158_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Newborns of HIV-infected mothers on ART were more likely to have low birth weight than newborns of HIV-uninfected mothers, suggesting an association of ART with low birth weight in newborns.\n                      <jats:italic>In utero<\/jats:italic>\n                      exposure of the foetus to ART might have influenced low birth weight in newborns through the promotion of endothelial dysfunction and oxidative stress.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2026-0158","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:55:51Z","timestamp":1789566951000},"source":"Crossref","is-referenced-by-count":0,"title":["Newborns of mothers living with HIV on antiretroviral treatment at late pregnancy are more likely to present low birth weight"],"prefix":"10.1515","author":[{"given":"Edna N.","family":"Matjuda","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Sciences, Department of Human Biology , Walter Sisulu University , Mthatha , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0044-9890","authenticated-orcid":false,"given":"Godwill A.","family":"Engwa","sequence":"additional","affiliation":[{"name":"Faculty of Natural Sciences, Department of Biological and Environmental Sciences , Walter Sisulu University , Mthatha , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandu","family":"Goswami","sequence":"additional","affiliation":[{"name":"Gravitational Physiology and Medicine Research Group, Physiology Division, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation , Medical University of Graz , Graz , Austria"},{"name":"Center for Space and Aviation Health , Mohammed Bin Rashid University of Medicine and Health Sciences , Dubai , United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance R.","family":"Sewani-Rusike","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sciences, Department of Human Biology , Walter Sisulu University , Mthatha , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4805-4051","authenticated-orcid":false,"given":"Benedicta N.","family":"Nkeh-Chungag","sequence":"additional","affiliation":[{"name":"Faculty of Natural Sciences, Department of Biological and Environmental Sciences , Walter Sisulu University , Mthatha , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091613554604466_j_jpm-2026-0158_ref_001","doi-asserted-by":"crossref","unstructured":"Jee, SB, Sawal, A. Physiological changes in pregnant women due to hormonal changes. Cureus 2024;16:e55544. https:\/\/doi.org\/10.7759\/cureus.55544.","DOI":"10.7759\/cureus.55544"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_002","doi-asserted-by":"crossref","unstructured":"Ramlakhan, KP, Johnson, MR, Roos-Hesselink, JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol 2020;17:718\u201331. https:\/\/doi.org\/10.1038\/s41569-020-0390-z.","DOI":"10.1038\/s41569-020-0390-z"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_003","doi-asserted-by":"crossref","unstructured":"Veihman, P, Kaw, S, Batey, DS, Schnall, R, Belloir, J. Pro-inflammatory biomarkers associated with depression severity among adults with HIV in New York City. J\u00a0Psychiatr Res 2025;191:148\u201354. https:\/\/doi.org\/10.1016\/j.jpsychires.2025.09.033.","DOI":"10.1016\/j.jpsychires.2025.09.033"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_004","unstructured":"Feinstein, MJ. HIV and cardiovascular disease: from insights to interventions. Top Antivir Med 2021;29:407\u201311."},{"key":"2026091613554604466_j_jpm-2026-0158_ref_005","unstructured":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013."},{"key":"2026091613554604466_j_jpm-2026-0158_ref_006","doi-asserted-by":"crossref","unstructured":"Siemieniuk, RA, Foroutan, F, Mirza, R, Mah Ming, J, Alexander, PE, Agarwal, A, et al.. Antiretroviral therapy for pregnant women living with HIV or Hepatitis B: a systematic review and meta-analysis. BMJ Open 2017;7:e019022. https:\/\/doi.org\/10.1136\/bmjopen-2017-019022.","DOI":"10.1136\/bmjopen-2017-019022"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_007","doi-asserted-by":"crossref","unstructured":"Pinnetti, C, Tintoni, M, Ammas-sari, A, Tamburrini, E, Bernardi, S, Liuzzi, G-P, et al.. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1. AIDS 2015;29:2534\u20137. https:\/\/doi.org\/10.1097\/qad.0000000000000888.","DOI":"10.1097\/QAD.0000000000000888"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_008","unstructured":"WHO. Recommends dolutegravir as preferred HIV treatment option in all populations; 2019. Available from: https:\/\/www.who.int\/news\/item\/22-07-2019-who-recommends-dolutegravir-as-preferred-hiv-treatment-option-in-all-populations [Accessed on 10 May 2023]."},{"key":"2026091613554604466_j_jpm-2026-0158_ref_009","doi-asserted-by":"crossref","unstructured":"Moorhouse, MA, Carmona, S, Davies, N, Dlamini, S, van Vuuren, C, Manzini, T, et al.. Southern African HIV clinicians society guidance on the use of dolutegravir in first-line antiretroviral therapy. South Afr J HIV Med 2018;19:917. https:\/\/doi.org\/10.4102\/sajhivmed.v19i1.917.","DOI":"10.4102\/sajhivmed.v19i1.917"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_010","doi-asserted-by":"crossref","unstructured":"Bourgi, K, Rebeiro, PF, Turner, M, Castilho, JL, Hulgan, T, Raffanti, SP, et al.. Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy. Clin Infect Dis 2020;70:1267\u201374. https:\/\/doi.org\/10.1093\/cid\/ciz407.","DOI":"10.1093\/cid\/ciz407"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_011","unstructured":"Sax, PE, Erlandson, KM, Lake, JE, Mccomsey, GA, Orkin, C, Esser, S, et al.. Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials. Clin Infect Dis 2019;68:535\u201344."},{"key":"2026091613554604466_j_jpm-2026-0158_ref_012","doi-asserted-by":"crossref","unstructured":"Caniglia, EC, Shapiro, R, Diseko, M, Wylie, BJ, Zera, C, Davey, S, et al.. Weight gain during pregnancy among women initiating dolutegravir in Botswana. EClinicalMedicine 2020;29-30:100615. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100615.","DOI":"10.1016\/j.eclinm.2020.100615"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_013","doi-asserted-by":"crossref","unstructured":"Saums, MK, King, CC, Adams, JC, Sheth, AN, Badell, ML, Young, M, et al.. Combination antiretroviral therapy and hypertensive disorders of pregnancy. Obstet Gynecol 2019;134:1205\u201314. https:\/\/doi.org\/10.1097\/aog.0000000000003584.","DOI":"10.1097\/AOG.0000000000003584"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_014","doi-asserted-by":"crossref","unstructured":"Ngono Ayissi, K, Gorwood, J, Le Pelletier, L, Bourgeois, C, Beaup\u00e8re, C, Auclair, M, et al.. Inhibition of adipose tissue beiging by HIV integrase inhibitors, dolutegravir and bictegravir, is associated with adipocyte hypertrophy, hypoxia, elevated fibrosis, and insulin resistance in simian adipose tissue and human adipocytes. Cells 2022;11:1841. https:\/\/doi.org\/10.3390\/cells11111841.","DOI":"10.3390\/cells11111841"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_015","doi-asserted-by":"crossref","unstructured":"Gorwood, J, Bourgeois, C, Pourcher, V, Pourcher, G, Charlotte, F, Mantecon, M, et al.. The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes. Clin Infect Dis 2020;71:e549\u201360. https:\/\/doi.org\/10.1093\/cid\/ciaa259.","DOI":"10.1093\/cid\/ciaa259"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_016","doi-asserted-by":"crossref","unstructured":"Bengtson, AM, Madlala, H, Matjila, MJ, Levitt, N, Goedecke, JH, Cu-Uvin, S, et al.. Associations of HIV and antiretroviral therapy with gestational diabetes in South Africa. AIDS 2023;37:2069\u201379. https:\/\/doi.org\/10.1097\/qad.0000000000003678.","DOI":"10.1097\/QAD.0000000000003678"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_017","doi-asserted-by":"crossref","unstructured":"Bengtson, AM, Madlala, H, Matjila, MJ, Goedecke, JH, Cu-Uvin, S, McGarvey, ST, et al.. Cardiometabolic health in pregnancy and postpartum: findings from a prospective cohort study in South Africa. Open Forum Infect Dis 2024;11:ofae093. https:\/\/doi.org\/10.1093\/ofid\/ofae093.","DOI":"10.1093\/ofid\/ofae093"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_018","doi-asserted-by":"crossref","unstructured":"Gongora, MC, Wenger, NK. Cardiovascular complications of pregnancy. Int J Mol Sci 2015;16:23905\u201328. https:\/\/doi.org\/10.3390\/ijms161023905.","DOI":"10.3390\/ijms161023905"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_019","doi-asserted-by":"crossref","unstructured":"Hoffman, RM, Newhouse, C, Chu, B, Stringer, JSA, Currier, JS. Non-communicable diseases in pregnant and postpartum women living with HIV: implications for health throughout the life course. Curr HIV AIDS Rep 2021;18:73\u201386. https:\/\/doi.org\/10.1007\/s11904-020-00539-6.","DOI":"10.1007\/s11904-020-00539-6"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_020","doi-asserted-by":"crossref","unstructured":"Deeks, SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011;62:141\u201355. https:\/\/doi.org\/10.1146\/annurev-med-042909-093756.","DOI":"10.1146\/annurev-med-042909-093756"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_021","doi-asserted-by":"crossref","unstructured":"Grieger, JA, Bianco-Miotto, T, Grzeskowiak, LE, Leemaqz, SY, Poston, L, McCowan, LM, et al.. Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: a prospective cohort of nulliparous women. PLoS Med 2018;15:e1002710. https:\/\/doi.org\/10.1371\/journal.pmed.1002710.","DOI":"10.1371\/journal.pmed.1002710"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_022","doi-asserted-by":"crossref","unstructured":"Grieger, JA, Hutchesson, MJ, Cooray, SD, Bahri Khomami, M, Zaman, S, Segan, L, et al.. A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum. Ther Adv Reprod Health 2021;15:2633494120986544. https:\/\/doi.org\/10.1177\/2633494120986544.","DOI":"10.1177\/2633494120986544"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_023","doi-asserted-by":"crossref","unstructured":"Madlala, HP, Myer, L, Jao, J, Geffen, H, Matjila, M, Fisher, A, et al.. Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study. J\u00a0Int AIDS Soc 2024;27:e26313. https:\/\/doi.org\/10.1002\/jia2.26313.","DOI":"10.1002\/jia2.26313"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_024","doi-asserted-by":"crossref","unstructured":"Li, H, Liu, J, Tan, D, Huang, G, Zheng, J, Xiao, J, et al.. Maternal HIV infection and risk of adverse pregnancy outcomes in Hunan Province, China: a prospective cohort study. Medicine 2020;99:e19213. https:\/\/doi.org\/10.1097\/md.0000000000019213.","DOI":"10.1097\/MD.0000000000019213"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_025","doi-asserted-by":"crossref","unstructured":"Matjuda, EN, Engwa, GA, Mungamba, MM, Sewani-Rusike, CR, Goswami, N, Nkeh-Chungag, BN. Cardio-metabolic health of offspring exposed in utero to human immuno-deficiency virus and anti-retroviral treatment: a systematic review. Biology 2024;13:32. https:\/\/doi.org\/10.3390\/biology13010032.","DOI":"10.3390\/biology13010032"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_026","doi-asserted-by":"crossref","unstructured":"Guerra, V, Leister, EC, Williams, PL, Starc, TJ, Lipshultz, SE, Wilkinson, JD, et al.. Long-term effects of in utero antiretroviral exposure: systolic and diastolic function in HIV-exposed uninfected youth. AIDS Res Hum Retrovir 2016;32:621\u20137. https:\/\/doi.org\/10.1089\/aid.2015.0281.","DOI":"10.1089\/aid.2015.0281"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_027","doi-asserted-by":"crossref","unstructured":"Nkeh-Chungag, BN, Engwa, GA, Businge, C, Mdondolo, M, Pajaro Medina, M, Goswami, N. Assessment of the impact of HIV infection and anti-retroviral treatment on the cardiometabolic health of pregnant mothers and their offspring (ARTMOMSBABES). BMC Cardiovasc Disord 2021;2021:322. https:\/\/doi.org\/10.1186\/s12872-021-02130-2.","DOI":"10.1186\/s12872-021-02130-2"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_028","unstructured":"World Health Organization. International statistical classification of diseases and related health problems, 10th revision, 5th ed. Geneva, Switzerland: World Health Organization; 2016. https:\/\/iris.who.int\/handle\/10665\/246208."},{"key":"2026091613554604466_j_jpm-2026-0158_ref_029","unstructured":"World Health Organization. Guidelines on basic newborn resuscitation. Geneva: World Health Organization; 2012. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK137872\/."},{"key":"2026091613554604466_j_jpm-2026-0158_ref_030","doi-asserted-by":"crossref","unstructured":"Madlala, HP, Malaba, TR, Newell, ML, Myer, L. Elevated body mass index during pregnancy and gestational weight gain in HIV-infected and HIV-uninfected women in Cape Town, South Africa: association with adverse birth outcomes. Trop Med Int Health 2020;25:702\u201313. https:\/\/doi.org\/10.1111\/tmi.13387.","DOI":"10.1111\/tmi.13387"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_031","doi-asserted-by":"crossref","unstructured":"Modjadji, P, Mokgalaboni, K, Nonterah, EA, Lebelo, SL, Mchiza, ZJ, Madiba, S, et al.. A systematic review on cardiometabolic risks and perinatal outcomes among pregnant women living with HIV in the era of antiretroviral therapy. Viruses 2023;15:1441. https:\/\/doi.org\/10.3390\/v15071441.","DOI":"10.3390\/v15071441"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_032","doi-asserted-by":"crossref","unstructured":"Wimalasundera, RC, Larbalestier, N, Smith, JH, de Ruiter, A, McG Thom, SA, Hughes, AD, et al.. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002;360:1152\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(02)11195-0.","DOI":"10.1016\/S0140-6736(02)11195-0"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_033","doi-asserted-by":"crossref","unstructured":"Stoner, MC, Vwalika, B, Smid, MC, George, S, Chi, BH, Stringer, EM, et al.. A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia. Int J Gynaecol Obstet 2016;134:299\u2013303. https:\/\/doi.org\/10.1016\/j.ijgo.2016.03.014.","DOI":"10.1016\/j.ijgo.2016.03.014"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_034","doi-asserted-by":"crossref","unstructured":"Hall, D, Gebhardt, S, Theron, G, Grove, D. Pre-eclampsia and gestational hypertension are less common in HIV infected women. Pregnancy Hypertens 2014;4:91\u20136. https:\/\/doi.org\/10.1016\/j.preghy.2013.11.008.","DOI":"10.1016\/j.preghy.2013.11.008"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_035","doi-asserted-by":"crossref","unstructured":"Sansone, M, Sarno, L, Saccone, G, Berghella, V, Maruotti, GM, Migliucci, A, et al.. Risk of preeclampsia in human immunodeficiency virus-infected pregnant women. Obstet Gynecol 2016;127:1027\u201332. https:\/\/doi.org\/10.1097\/aog.0000000000001424.","DOI":"10.1097\/AOG.0000000000001424"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_036","doi-asserted-by":"crossref","unstructured":"Tooke, LRL, Manila, M, Harrison, M. Antiretrovirals causing severe pre-eclampsia. Pregnancy Hypertens 2016;6:266\u20138. https:\/\/doi.org\/10.1016\/j.preghy.2016.04.006.","DOI":"10.1016\/j.preghy.2016.04.006"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_037","doi-asserted-by":"crossref","unstructured":"Bush, KNV, Teel, JL, Watts, JA, Gore, RS, Alvarado, G, Harper, NL, et al.. Association of endothelial dysfunction and antiretroviral therapy in early HIV infection. JAMA Netw Open 2019;2:e1913615. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.13615.","DOI":"10.1001\/jamanetworkopen.2019.13615"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_038","doi-asserted-by":"crossref","unstructured":"Schmidt-Lucke, C, Belgore, F, Reinhold, D, Ansorge, S, Klein, HU, Schmidt-Lucke, AJ, et al.. Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. Int J Cardiol 2005;100:207\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2004.05.046.","DOI":"10.1016\/j.ijcard.2004.05.046"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_039","doi-asserted-by":"crossref","unstructured":"Neves, KB, Rios, FJ, van der Mey, L, Alves-Lopes, R, Cameron, AC, Volpe, M, et al.. VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes. Hypertension 2018;71:638\u201347. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10490.","DOI":"10.1161\/HYPERTENSIONAHA.117.10490"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_040","doi-asserted-by":"crossref","unstructured":"Dubova, EA, Pavlov, KA, Borovkova, EI, Bayramova, MA, Makarov, IO, Shchegolev, AI. Vascular endothelial growth factor and its receptors in the placenta of pregnant women with obesity. Bull Exp Biol Med 2011;151:253\u20138. https:\/\/doi.org\/10.1007\/s10517-011-1302-3.","DOI":"10.1007\/s10517-011-1302-3"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_041","doi-asserted-by":"crossref","unstructured":"Zhang, Z, Zhao, L, Zhou, X, Meng, X, Zhou, X. Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front Immunol 2023;13:1098725. https:\/\/doi.org\/10.3389\/fimmu.2022.1098725.","DOI":"10.3389\/fimmu.2022.1098725"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_042","doi-asserted-by":"crossref","unstructured":"Mokoena, H, Mabhida, SE, Choshi, J, Dludla, PV, Nkambule, BB, Mchiza, ZJ, et al.. Endothelial dysfunction and cardiovascular diseases in people living with HIV on specific highly active antiretroviral therapy regimen: a systematic review of clinical studies. Atheroscler Plus 2024;55:47\u201354. https:\/\/doi.org\/10.1016\/j.athplu.2024.01.003.","DOI":"10.1016\/j.athplu.2024.01.003"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_043","doi-asserted-by":"crossref","unstructured":"Bae, YS, Lee, JH, Choi, SH, Kim, S, Almazan, F, Witztum, JL, et al.. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4\u2013and spleen tyrosine kinase\u2013\u00a0dependent activation of NADPH oxidase 2. Circ Res 2009;104:210\u201318. https:\/\/doi.org\/10.1161\/circresaha.108.181040.","DOI":"10.1161\/CIRCRESAHA.108.181040"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_044","doi-asserted-by":"crossref","unstructured":"Kurashova, N, Petrova, AG, Vanyarkina, AS, Rychkova, LV, Darenskaya, M, Moskaleva, E, et al.. Blood integrated indicator of oxidative stress in infants born to HIV-infected mothers. Yakut Med J 2023;83:75\u20138. https:\/\/doi.org\/10.25789\/ymj.2023.83.19.","DOI":"10.25789\/YMJ.2023.83.19"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_045","doi-asserted-by":"crossref","unstructured":"Kurashova, NA, Vanyarkina, AS, Petrova, AG, Rychkova, LV, Kolesnikov, SI, Darenskaya, MA, et al.. Features of the free radical oxidation process and antioxidant system in newborns born to HIV-infected of mothers who received antiretroviral therapies to prevent HIV transmission. Bull Exp Biol Med 2023;174:413\u201316. https:\/\/doi.org\/10.1007\/s10517-023-05719-z.","DOI":"10.1007\/s10517-023-05719-z"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_046","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez, S, Catal\u00e1n-Garc\u00eda, M, Mor\u00e9n, C, Garc\u00eda-Otero, L, L\u00f3pez, M, Guitart-Mampel, M, et al.. Placental mitochondrial toxicity, oxidative stress, apoptosis, and adverse perinatal outcomes in HIV pregnancies under antiretroviral treatment containing zidovudine. J\u00a0Acquir Immune Defic Syndr 2017;75:e113\u201319. https:\/\/doi.org\/10.1097\/qai.0000000000001334.","DOI":"10.1097\/QAI.0000000000001334"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_047","doi-asserted-by":"crossref","unstructured":"Martinez Manfio, V, Tasca, KI, Garcia, JL, de Oliveira G\u00f3is, J, Correa, CR. de Souza LdR Redox imbalance is related to HIV and pregnancy. PLoS One 2021;16:e0251619. https:\/\/doi.org\/10.1371\/journal.pone.0251619.","DOI":"10.1371\/journal.pone.0251619"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_048","doi-asserted-by":"crossref","unstructured":"Gandhi, RT, McMahon, DK, Bosch, RJ, Lalama, CM, Cyktor, JC, Macatangay, BJ, et al.. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathog 2017;13:e1006285. https:\/\/doi.org\/10.1371\/journal.ppat.1006285.","DOI":"10.1371\/journal.ppat.1006285"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_049","doi-asserted-by":"crossref","unstructured":"Wada, NI, Jacobson, LP, Margolick, JB, Breen, EC, Macatangay, B, Penugonda, S, et al.. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 2015;29:463\u201371. https:\/\/doi.org\/10.1097\/qad.0000000000000545.","DOI":"10.1097\/QAD.0000000000000545"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_050","doi-asserted-by":"crossref","unstructured":"Matjuda, EN, Engwa, GA, Sewani-Rusike, CR, Nkeh-Chungag, BN. An overview of vascular dysfunction and determinants: the case of children of African ancestry. Front Pediatr 2021;9:769589. https:\/\/doi.org\/10.3389\/fped.2021.769589.","DOI":"10.3389\/fped.2021.769589"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_051","doi-asserted-by":"crossref","unstructured":"Mohammadi, H, Papp, E, Cahill, L, Rennie, M, Banko, N, Pinnaduwage, L, et al.. HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation. Sci Rep 2018;8:6552. https:\/\/doi.org\/10.1038\/s41598-018-24680-w.","DOI":"10.1038\/s41598-018-24680-w"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_052","doi-asserted-by":"crossref","unstructured":"Kirshenbaum, M, Topaz, L, Baum, M, Mazaki-Tovi, S, Yinon, Y. Is endothelial function impaired among women with placenta-mediated fetal growth restriction? Evidence from a prospective cohort study using peripheral artery tonometry. Placenta 2021;109:32\u20136. https:\/\/doi.org\/10.1016\/j.placenta.2021.04.013.","DOI":"10.1016\/j.placenta.2021.04.013"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_053","doi-asserted-by":"crossref","unstructured":"Zotova, N, Munyaneza, A, Murenzi, G, Kubwimana, G, Adedimeji, A, Anastos, K, et al.. Low birth weight and adverse pregnancy outcomes among women living with HIV and HIV-uninfected in Rwanda. PLoS One 2025;20:e0329312. https:\/\/doi.org\/10.1371\/journal.pone.0329312.","DOI":"10.1371\/journal.pone.0329312"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_054","doi-asserted-by":"crossref","unstructured":"De la Calle, M, Rodriguez, R, Deir\u00f3s, L, Bartha, JL. Fetal cardiac biometry and function in HIV-infected pregnant women exposed to HAART therapy. Prenat Diagn 2015;35:453\u20135. https:\/\/doi.org\/10.1002\/pd.4549.","DOI":"10.1002\/pd.4549"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_055","doi-asserted-by":"crossref","unstructured":"Sofeu, CL, Warszawski, J, Ateba, NF, Penda, IC, Tetang, NS, Guemkam, G, et al.. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. PLoS One 2014;9:e93554. https:\/\/doi.org\/10.1371\/journal.pone.0093554.","DOI":"10.1371\/journal.pone.0093554"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_056","doi-asserted-by":"crossref","unstructured":"Nyemba, DC, Kalk, E, Madlala, HP, Malaba, TR, Slogrove, AL, Davies, MA, et al.. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa. BMC Pregnancy Childbirth 2021;21:354. https:\/\/doi.org\/10.1186\/s12884-021-03836-z.","DOI":"10.1186\/s12884-021-03836-z"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_057","doi-asserted-by":"crossref","unstructured":"Ramokolo, V, Goga, AE, Lombard, C, Doherty, T, Jackson, DJ, Engebretsen, I. In utero ART exposure and birth and early growth outcomes among HIV-exposed uninfected infants attending immunization services: results from national PMTCT surveillance, South Africa. Open Forum Infect Dis 2017;4:ofx187. https:\/\/doi.org\/10.1093\/ofid\/ofx187.","DOI":"10.1093\/ofid\/ofx187"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_058","doi-asserted-by":"crossref","unstructured":"Malaba, TR, Phillips, T, Le Roux, S, Brittain, K, Zerbe, A, Petro, G, et al.. Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women. Int J Epidemiol 2017;46:1678\u201389. https:\/\/doi.org\/10.1093\/ije\/dyx136.","DOI":"10.1093\/ije\/dyx136"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_059","doi-asserted-by":"crossref","unstructured":"Chalashika, P, Essex, C, Mellor, D, Swift, JA, Langley-Evans, S. Birthweight, HIV exposure and infant feeding as predictors of malnutrition in Botswanan infants. J\u00a0Hum Nutr Diet 2017;30:779\u201390. https:\/\/doi.org\/10.1111\/jhn.12517.","DOI":"10.1111\/jhn.12517"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_060","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, R, Rup\u00e9rez, M, Sevene, E, Vala, A, Maculuve, S, Bulo, H, et al.. Effects of HIV infection on maternal and neonatal health in southern Mozambique: a prospective cohort study after a decade of antiretroviral drugs roll out. PLoS One 2017;12:e0178134. https:\/\/doi.org\/10.1371\/journal.pone.0178134.","DOI":"10.1371\/journal.pone.0178134"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_061","doi-asserted-by":"crossref","unstructured":"Hofer, CB, Keiser, O, Zwahlen, M, Lustosa, CS, Cisne, FAC, de Oliveira, RH, et al.. In utero exposure to antiretroviral drugs: effect on birth weight and growth among HIV-exposed uninfected children in Brazil. Pediatr Infect Dis J 2016;35:71. https:\/\/doi.org\/10.1097\/inf.0000000000000926.","DOI":"10.1097\/INF.0000000000000926"},{"key":"2026091613554604466_j_jpm-2026-0158_ref_062","doi-asserted-by":"crossref","unstructured":"Barker, DJ, Osmond, C, Simmonds, SJ, Wield, GA. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. Br Med J 1993;306:422\u20136. https:\/\/doi.org\/10.1136\/bmj.306.6875.422.","DOI":"10.1136\/bmj.306.6875.422"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2026-0158\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2026-0158\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:56:25Z","timestamp":1789566985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2026-0158\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":62,"alternative-id":["10.1515\/jpm-2026-0158"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2026-0158","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}